首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1643930

全球子宮操縱器械市場 - 2025-2033

Global Uterine Manipulation Devices Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球子宮操縱器械市場達到2.937億美元，預計到2033年將達到4.877億美元，2025-2033年預測期間複合年成長率為5.8%。

子宮操縱裝置是專門的手術器械，旨在協助婦科醫生在各種微創和開放手術過程中定位、穩定和活動子宮。這些設備在腹腔鏡、子宮鏡和其他婦科手術中尤其重要，可以實現精確的子宮運動，從而提高手術通道、視覺化和整體手術效率。子宮操縱器有一次性（一次性）型號，可增強無菌性，也有可重複使用設計，可提高成本效益，取決於臨床偏好。

微創婦科手術的日益普及、對女性健康問題的認知不斷增強以及手術技術的進步推動了對子宮操縱設備的需求。例如，根據 ScienceDirect 發表的文章，在微創子宮切除術中經常使用子宮操縱器，以改善進入手術區域的機會，並作為陰道切開術的里程碑。先前的研究表明，在子宮內膜癌微創手術中，操縱子宮器的使用率在 42-90% 之間。

市場動態：

驅動程式和限制

婦科疾病盛行率上升

子宮肌瘤、子宮內膜異位症和子宮癌等婦科疾病的盛行率不斷上升，大大推動了子宮操縱裝置市場的成長，預計將在預測期內推動市場成長。由於這些情況通常需要手術干預，因此對子宮操縱器等有效工具的需求不斷增加。

根據美國國立衛生研究院(NIH) 的數據，子宮肌瘤也稱為子宮肌瘤，主要困擾整個育齡期的女性，高達70% 的白人女性和超過80% 的非裔美國女性在一生中都可發現子宮肌瘤。許多患有肌瘤的女性接受子宮肌瘤切除術（肌瘤切除術）或子宮切除術，這兩種手術都需要子宮操縱裝置才能獲得最佳手術結果，特別是在腹腔鏡手術等微創手術中。

例如，根據美國國立衛生研究院 (NIH) 的數據，子宮切除術是美國女性最常見的手術之一，每年總共進行約 60 萬例手術，其中約 10% 的手術是次全切除（保留子宮頸）其中很大一部分手術是由於子宮肌瘤而進行的，這就產生了對子宮操縱器的需求。

根據世界衛生組織 (WHO) 的數據，子宮內膜異位症影響全球約 10%（1.9 億）的育齡婦女和女孩，其中很大一部分需要手術干預來控制症狀或保留生育能力。子宮內膜異位症的手術通常涉及腹腔鏡檢查，在此過程中使用子宮操縱裝置來重新定位和穩定子宮，以便於移除子宮內膜組織。

此外，美國癌症協會預測，2024 年美國將診斷出約 67,880 例新子宮癌病例。治療通常包括子宮切除術或淋巴結切除術，其中子宮操縱裝置有助於定位子宮，以便更安全、更有效地進行手術切除。

設備相關併發症的風險

與設備相關的併發症的風險預計將阻礙子宮操縱設備市場的成長。儘管這些設備在手術過程中具有精確性和效率方面的優勢，但子宮穿孔、感染和設備處理不當等併發症可能會導致不良後果，這可能會阻止醫療保健提供者採用這些設備。

當機械手尖端無意中刺穿子宮壁時，就會發生子宮穿孔，導致出血、感染和周圍器官損傷等嚴重併發症。例如，根據美國國立衛生研究院（NIH）的研究，在子宮內膜癌微創手術中使用機械手和子宮穿孔的研究發現，子宮穿孔率為11%。

使用子宮操縱裝置時，感染是另一個問題，特別是當裝置未正確消毒或子宮腔在手術過程中受到污染時。例如，根據《美國婦產科雜誌》的一項研究，大約 2-5% 的腹腔鏡手術會發生手術部位感染。然而，如果手術工具消毒不當，這一比率可能會增加。

市場領導者和先驅
- 新興先鋒和傑出參與者
- 擁有最大銷售品牌的知名領導者
- 擁有成熟產品的市場領導者
新興新創企業和關鍵創新者
CXO 觀點
最新進展和突破
案例研究/正在進行的研究
監管和報銷情況
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東和非洲
波特五力分析
供應鏈分析
SWOT分析
未滿足的需求和差距
市場進入和擴張的推薦策略
情境分析：最佳情況、基本情況和最壞情況預測
定價分析和價格動態

第 5 章：子宮操縱設備市場（按類型）

一次性子宮操縱器
可重複使用的子宮操縱器

第 6 章：子宮操縱裝置市場（依應用）

全腹腔鏡子宮切除術 (TLH)
腹腔鏡子宮頸上子宮切除術 (LSH)
腹腔鏡輔助陰式子宮切除術 (LAVH)
骶骨陰道固定術
其他

第 7 章：子宮操縱設備市場（依照最終用戶）

醫院
婦科專科診所
門診手術中心
其他

第 8 章：子宮操縱裝置市場，按區域市場分析和成長機會

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
南美洲
- 巴西
- 阿根廷
- 南美洲其他地區
亞太
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲

第 9 章：競爭格局與市場定位

競爭概況和主要市場參與者
市佔率分析與定位矩陣
策略夥伴關係、併購
產品組合和創新的主要發展
公司基準化分析

第 10 章：公司簡介

B. Braun Melsungen AG

公司概況
產品組合和描述
財務概覽
主要進展
SWOT分析

CONMED Corporation
CooperSurgical Inc.
Normedi, a Hologic Company
KARL STORZ SE & Co. KG
Conkin Surgical Instrument Ltd.
Richard Wolf GmbH
Purple Surgical
Utah Medical Products, Inc.
LABORIE MEDICAL TECHNOLOGIES CORP.

第 11 章：假設與研究方法

資料收集方法
數據三角測量
預測技術
數據驗證和確認

第 12 章：附錄

簡介目錄

Product Code: MD6748

The global uterine manipulation devices market reached US$ 293.7 million in 2024 and is expected to reach US$ 487.7 million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

Uterine manipulation devices are specialized surgical instruments designed to assist gynecological surgeons in positioning, stabilizing, and mobilizing the uterus during various minimally invasive and open surgical procedures. These devices are particularly critical in laparoscopic, hysteroscopic and other gynecological surgeries, enabling precise uterine movement to enhance surgical access, visualization, and overall procedural efficiency. Uterine manipulators are available in single-use (disposable) models for enhanced sterility and reusable designs for cost-effectiveness, depending on clinical preferences.

The demand for uterine manipulation devices is driven by the increasing adoption of minimally invasive gynecological surgeries, a growing awareness of women's health issues and advancements in surgical technologies. For instance, according to the article publised by the ScienceDirect, a uterine manipulator is frequently utilized during a minimally invasive hysterectomy to improve access to the surgical field and serve as a landmark for colpotomy. Prior studies have indicated rates of uterine manipulator use between 42-90 % during minimally invasive surgeries for endometrial cancer.

Market Dynamics: Drivers & Restraints

Rising prevalence of gynecological disorders

The rising prevalence of gynecological disorders such as uterine fibroids, endometriosis and uterine cancer is significantly driving the growth of the uterine manipulation devices market and is expected to drive the market over the forecast period. As these conditions often require surgical intervention, the demand for effective tools, such as uterine manipulators, has risen.

According to the National Institute of Health (NIH), Uterine leiomyomas also known as fibroids, mostly afflict women throughout their reproductive years and are detected in up to 70% of white women and more than 80% of African-American women over their lifespan. Many women with fibroids undergo myomectomy (fibroid removal) or hysterectomy, both of which require uterine manipulation devices for optimal surgical outcomes, especially in minimally invasive procedures like laparoscopic surgeries.

For instance, according to the National Institute of Health (NIH), hysterectomy is one of the most common surgeries performed in women in the United States, totaling roughly 600,000 procedures each year, with approximately 10% of procedures being subtotal (cervix-preserving) and a significant number of these surgeries are due to fibroids, creating demand for uterine manipulators.

According to the World Health Organization (WHO), endometriosis affects roughly 10% (190 million) of reproductive-age women and girls globally, with a significant percentage requiring surgical intervention for symptom management or fertility preservation. Surgery for endometriosis often involves laparoscopy, during which uterine manipulation devices are used to reposition and stabilize the uterus, facilitating the removal of endometrial tissue.

Additionally, the American Cancer Society forecasts for cancer of the uterus in the United States in 2024 approximately 67,880 new cases of uterine cancer will be diagnosed. Treatment often involves hysterectomy or lymphadenectomy, where uterine manipulation devices assist in positioning the uterus for safer and more effective surgical removal.

Risk of device-related complications

The risk of device-related complications is expected to hamper the growth of the uterine manipulation devices market. Despite the advantages these devices offer in terms of precision and efficiency during surgical procedures, complications such as uterine perforation, infection, and improper device handling can lead to adverse outcomes, which may deter healthcare providers from adopting these devices.

Uterine perforation occurs when the manipulator tip inadvertently punctures the uterine wall, leading to significant complications such as bleeding, infection, and injury to surrounding organs. For instance, according to the study conducted by the National Institute of Health (NIH), the use of uterine manipulators and uterine perforation in minimally invasive endometrial cancer surgery study found a uterine perforation rate of 11%.

Infection is another concern when using uterine manipulation devices, particularly when the device is not properly sterilized or if the uterine cavity is contaminated during the procedure. For instance, according to a study in the American Journal of Obstetrics & Gynecology, surgical site infections occur in about 2-5% of laparoscopic surgeries. However, this rate can increase in the case of improper sterilization of surgical tools.

Segment Analysis

The global uterine manipulation devices market is segmented based on type, application, end-user and region.

Application:

The total laparoscopic hysterectomy (TLH) segment is expected to dominate the uterine manipulation devices market share

Total laparoscopic hysterectomy (TLH) is a minimally invasive surgical procedure used to remove the uterus, and it is the dominant segment in the uterine manipulation devices market. The increasing preference for TLH, due to its numerous advantages over traditional open surgery, such as reduced recovery time, lower risk of complications, and better cosmetic outcomes, has made it a key driver of demand for uterine manipulation devices.

The demand for uterine manipulation devices in TLH is particularly high because these devices enhance the precision of the surgery by stabilizing and positioning the uterus, which is vital for laparoscopic access. For instance, according to the American College of Obstetricians and Gynecologists, 70-80% of hysterectomies in the U.S. are now performed laparoscopically, with TLH being the preferred method, further driving the growth of uterine manipulation devices in this segment.

The adoption rate of TLH is growing due to its many advantages over abdominal hysterectomy, such as faster recovery time, less blood loss, and fewer post-operative complications. As more hospitals and clinics adopt TLH as the standard for hysterectomy, the use of uterine manipulation devices has correspondingly increased. For instance, in the U.S., TLH procedures increased by over 15% annually from 2010 to 2020, and this growth is expected to continue as TLH becomes the preferred method for hysterectomy worldwide.

Geographical Analysis

North America is expected to hold a significant position in the uterine manipulation devices market share

North America especially the United States performs hundreds of thousands of hysterectomies annually, the majority of which are now laparoscopic procedures. With TLH being the most common method, uterine manipulation devices are in high demand to ensure the success and precision of these surgeries. For instance, according to the National Institute of Health (NIH), hysterectomy is one of the most common surgeries performed in women in the United States, with 600,000 procedures each year.

North American medical device manufacturers are leaders in developing and improving uterine manipulation devices, incorporating advanced features such as better ergonomics, user-friendly interfaces, and enhanced safety features. This innovation attracts hospitals and surgical centers in the region to adopt these devices more frequently.

For instance, leading manufacturers in North America, like CooperSurgical, produce high-quality uterine manipulators that are widely used in TLH procedures across the region. The RUMI II manipulator is a notable example, widely adopted in U.S. hospitals for its advanced design and effectiveness in TLH.

Asia-Pacific is growing at the fastest pace in the uterine manipulation devices market

In Asia-Pacific, especially in Japan, China and India, laparoscopic surgery, including total laparoscopic hysterectomy, is becoming the preferred method for hysterectomy in the region due to its minimally invasive nature, which reduces recovery times and healthcare costs. As more surgeons and hospitals in the region adopt minimally invasive techniques, the demand for uterine manipulators, which are essential in laparoscopic procedures, has surged.

For instance, according to the National Institute of Health, in Japan, over 50% of hysterectomies are now performed laparoscopically, and this trend is rapidly growing across other APAC nations. In China, laparoscopic hysterectomy adoption rates have increased by 18-20% annually over the past decade.

The Asia-Pacific region is becoming a global hub for medical tourism, with countries like Thailand, India, and Malaysia attracting patients for affordable, high-quality medical procedures. Many of these patients undergo laparoscopic surgeries, which require uterine manipulation devices. The increase in surgical volume, driven by medical tourism and local patients, boosts the demand for uterine manipulators, particularly in countries with established medical tourism industries.

Competitive Landscape

The major global players in the uterine manipulation devices market include B. Braun Melsungen AG, CONMED Corporation, CooperSurgical Inc., Normedi, a Hologic Company, KARL STORZ SE & Co. KG, Conkin Surgical Instrument Ltd., Richard Wolf GmbH, Purple Surgical, Utah Medical Products, Inc., LABORIE MEDICAL TECHNOLOGIES CORP. and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global uterine manipulation devices market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 158 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Market Introduction and Scope

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. Executive Insights and Key Takeaways

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region

3. Dynamics

3.1. Impacting Factors
- 3.1.1. Drivers
  - 3.1.1.1. Rising Prevalence of Gynecological Disorders
- 3.1.2. Restraints
  - 3.1.2.1. Risk of Device-Related Complications
- 3.1.3. Opportunity
- 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

4.1. Market Leaders and Pioneers
- 4.1.1. Emerging Pioneers and Prominent Players
- 4.1.2. Established leaders with largest selling Brand
- 4.1.3. Market leaders with established Product
4.2. Emerging Startups and Key Innovators
4.3. CXO Perspectives
4.4. Latest Developments and Breakthroughs
4.5. Case Studies/Ongoing Research
4.6. Regulatory and Reimbursement Landscape
- 4.6.1. North America
- 4.6.2. Europe
- 4.6.3. Asia Pacific
- 4.6.4. Latin America
- 4.6.5. Middle East & Africa
4.7. Porter's Five Force Analysis
4.8. Supply Chain Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics

5. Uterine Manipulation Devices Market, By Type

5.1. Introduction
- 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 5.1.2. Market Attractiveness Index, By Type
5.2. Disposable Uterine Manipulators*
- 5.2.1. Introduction
- 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Reusable Uterine Manipulators

6. Uterine Manipulation Devices Market, By Application

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 6.1.2. Market Attractiveness Index, By Application
6.2. Total Laparoscopy Hysterectomy (TLH) *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Laparoscopic Supracervical Hysterectomy (LSH)
6.4. Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
6.5. Sacrocolpopexy
6.6. Others

7. Uterine Manipulation Devices Market, By End-User

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialized Gynecology Clinics
7.4. Ambulatory Surgical Centers
7.5. Others

8. Uterine Manipulation Devices Market, By Regional Market Analysis and Growth Opportunities

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
- 8.2.1. Introduction
- 8.2.2. Key Region-Specific Dynamics
- 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.2.6.1. U.S.
  - 8.2.6.2. Canada
  - 8.2.6.3. Mexico
8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Key Region-Specific Dynamics
- 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.3.6.1. Germany
  - 8.3.6.2. U.K.
  - 8.3.6.3. France
  - 8.3.6.4. Spain
  - 8.3.6.5. Italy
  - 8.3.6.6. Rest of Europe
8.4. South America
- 8.4.1. Introduction
- 8.4.2. Key Region-Specific Dynamics
- 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.4.6.1. Brazil
  - 8.4.6.2. Argentina
  - 8.4.6.3. Rest of South America
8.5. Asia-Pacific
- 8.5.1. Introduction
- 8.5.2. Key Region-Specific Dynamics
- 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 8.5.6.1. China
  - 8.5.6.2. India
  - 8.5.6.3. Japan
  - 8.5.6.4. South Korea
  - 8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
- 8.6.1. Introduction
- 8.6.2. Key Region-Specific Dynamics
- 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking

10. Company Profiles

10.1. B. Braun Melsungen AG*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
- 10.1.5. SWOT Analysis
10.2. CONMED Corporation
10.3. CooperSurgical Inc.
10.4. Normedi, a Hologic Company
10.5. KARL STORZ SE & Co. KG
10.6. Conkin Surgical Instrument Ltd.
10.7. Richard Wolf GmbH
10.8. Purple Surgical
10.9. Utah Medical Products, Inc.
10.10. LABORIE MEDICAL TECHNOLOGIES CORP.